Muhammad Al-Hajj
Chief Tech/Sci/R&D Officer bei IO BIOTECH, INC.
Vermögen: - $ am 31.03.2024
Profil
Muhammad Al-Hajj is currently the Chief Scientific Officer at IO Biotech, Inc. Prior to this, he worked as the Senior Director-Biology & Trans Med at GSK Plc from 2009 to 2015, and as the VP-Drug Discovery & Translational Medicine at Sanford Burnham Prebys Medical Discovery Institute from 2015 to 2017.
He also held the position of Senior Vice President-Translational Sciences at Autolus Ltd.
Dr. Al-Hajj earned a doctorate degree from the University of Michigan Comprehensive Cancer Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IO BIOTECH, INC.
-.--% | 20.03.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Muhammad Al-Hajj
| Unternehmen | Position | Beginn |
|---|---|---|
| IO BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 01.05.2021 |
Ehemalige bekannte Positionen von Muhammad Al-Hajj
| Unternehmen | Position | Ende |
|---|---|---|
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01.06.2017 |
| GSK PLC | Corporate Officer/Principal | 01.04.2015 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Muhammad Al-Hajj
| University of Michigan Comprehensive Cancer Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| IO BIOTECH, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
